Abstract Context The European Association of Urology (EAU) has released an updated
version of the guidelines on non–muscle-invasive bladder cancer (NMIBC). Objective To …

Bladder cancer is among the ten most common cancers globally, causes considerable
morbidity and mortality and is, therefore, a substantial burden for health-care systems. The …

Background and objective This publication represents a summary of the updated 2024
European Association of Urology (EAU) guidelines for non–muscle-invasive bladder cancer …

Bladder cancer ranks among the most common cancers globally. At diagnosis, 75% of
patients have non-muscle-invasive bladder cancer (NMIBC). Patients with low-risk NMIBC …

Simple Summary Bacillus Calmette–Guérin (BCG), a live attenuated strain of Mycobacterium
bovis, is the most successful microbial immunotherapy of cancer in current use. Intravesical …

Abstract Background The 2021 European Association of Urology (EAU) guidelines contain
updated prognostic factor risk groups for non–muscle-invasive bladder cancer (NMIBC) …

Grade is a key prognostic factor in determining progression in nonmuscle invasive papillary
urothelial carcinomas. The 2 most common grading methods in use worldwide are the World …

Context Grading is the mainstay for treatment decisions for patients with non–muscle-
invasive bladder cancer (NMIBC). Objective To determine the requirements for an optimal …

Objective We report NHS England data for patients with bladder cancer (BC), upper tract
urothelial cancer (UTUC: renal pelvic and ureteric), and urethral cancers from 2013 to 2019 …

Abstract Objectives To evaluate whether Vesical Imaging-Reporting And Data System (VI-
RADS) scores based on multiparametric MRI (mp-MRI) can predict bladder cancer (BCa) …